GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Synageva BioPharma Corp's marketable securities for the quarter that ended in Mar. 2015 was $611.98 Mil.
Synageva BioPharma Corp's quarterly marketable securities declined from Sep. 2014 ($411.85 Mil) to Dec. 2014 ($364.26 Mil) but then increased from Dec. 2014 ($364.26 Mil) to Mar. 2015 ($611.98 Mil).
Synageva BioPharma Corp's annual marketable securities increased from Dec. 2012 ($195.07 Mil) to Dec. 2013 ($346.60 Mil) and increased from Dec. 2013 ($346.60 Mil) to Dec. 2014 ($364.26 Mil).
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.
Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' marketable securities also includes "Other Short Term Investment".
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data